Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Corydalis bungeana is a perennial herb widely used in traditional Mongolian and Chinese medicine. The dried whole plant, known as Herba Corydalis Bungeanae, contains several bioactive alkaloids such as corydaline, 12-hydroxycorynoline, protopine, acetylcorynoline, and especially corynoline. It has been traditionally applied for its anti-inflammatory effects and to treat conditions like influenza and upper respiratory tract infections. Recent studies have demonstrated that extracts of Corydalis bungeana exhibit weight loss and lipid-lowering effects in animal models of obesity by regulating lipid and glucose metabolism[1]. Its anti-inflammatory mechanism involves suppression of the Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway through inhibition of IκBα and p65 phosphorylation[6], reduction of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β), activation of the Nuclear factor erythroid 2-related factor 2 (Nrf2)/ARE pathway[5], and immune regulatory functions. The main active compounds are alkaloids (notably corynoline), steroids, and flavonoid glycosides[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on corydalis bungeana.